Alzheimer's Early Stages: First Steps In Care and Treatment, by Daniel Kuhn and David A. Bennett. (Hunter House, 1999 (1st edition) , 274 pp., $14.95). This guidebook focuses on the medical aspects of the disease and includes a comparison of the normal aging pattern of the brain and the effects of Alzheimer's. Discusses long-term planning, relationships, communication, and how to stay healthy while caring for someone with Alzheimer's.

Articles

Cognitive decline and literacy among ethnically diverse elders, by Jennifer Manly and others. (Journal of Geriatric Psychology and Neurology, 2005, Vol. 18. pp. 213-217.)

“Racial differences in the progression of cognitive decline in Alzheimer disease,” by Lisa L. Barnes and others. (American Journal of Geriatric Psychology, November 2005, Vol. 13, pp. 1-9.)

“Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community,” by Jennifer J. Manly and others. (Archives of Neurology, November 2005, Vol. 62, pp. 1739-1746.)

“Potential ethnic modifiers in the assessment and treatment of Alzheimer’s disease: challenges for the future,” by Warachal E. Faison and others. (International Psychogeriatrics, 2007, Vol. 19, pp. 539-558.)

“Cognitive functioning among African American older adults,” By Sheila Black. (African American Research Perspectives, Spring/Summer 2004, Vol. 10, Issue 1, pp. 106-118.)

"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B," by William E. Klunk and others. (Annals of Neurology, March 2004, Volume 55, Number 3, pp. 306-319.)

"Guidance on the use of donepezil, rivastigmine, and galantamine for the treatment of Alzheimer's disease," by the National Institute for Clinical Excellence (NICE). (Technology Appraisal Guidance No. 19, January 2001. Article available online: www.nice.org.uk

"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial," by Timo Erkinjuntti, et al. (Lancet, April 13, 2002, Volume 359, pp. 1283-1290.

"Galantamine for Alzheimer's disease (Cochrane Review)," by J. Olin and L. Schneider. (Cochrane Database Systematic Review 2001; 4: CD001747.)

"Practice parameter: management of dementia (an evidence-based review)," by the Quality Standards Subcommittee of the American Academy of Neurology. (Neurology, 2001, Volume 56, pp. 1154-1166.)

"Use of acetylcholinesterase inhibitors in Alzheimer's disease," by Shehram Moghul and David Wilkinson. (Expert Reviews in Neurotherapeutics, 2001, Volume 1, Number 1, pp. 61-69.) Article available online: www.future-drugs.com

Associations and Websites

Alzheimer's Disease Education and Referral center (ADEAR)
P.O. Box 8250
Silver Spring, MD 20907-8250
800-438-4380
Email: adear@alzheimers.org